SEC Form 4 research
| Issuer | Royalty Pharma plc |
|---|---|
| Tickers | RPRX |
| Reporting owners | 33 |
| Officers and directors | 11 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-06 | 2026-11-04 | Coyne Terrance P. | A | 7,122 | $0 | Not reported |
| 2026-11-06 | 2026-11-04 | Urist Marshall | A | 5,341 | $0 | Not reported |
| 2026-11-06 | 2026-11-04 | Legorreta Pablo G. | A | 42,209 | $0 | Not reported |
| 2026-11-06 | 2026-11-04 | Hite Christopher | A | 7,122 | $0 | Not reported |
| 2026-10-05 | 2026-10-05 | Urist Marshall | S | 4,126 | $57.1 | Not reported |
| 2026-09-30 | 2026-09-30 | Bassler Bonnie L | A | 642 | $58.41 | Not reported |
| 2026-09-30 | 2026-09-28 | Urist Marshall | S | 4,126 | $57.88 | Not reported |
| 2026-09-24 | 2026-09-22 | Hite Christopher | S | 3,927 | $58.93 | Not reported |
| 2026-09-24 | 2026-09-22 | Hite Christopher | S | 96,073 | $58.51 | Not reported |
| 2026-08-19 | 2026-08-18 | Hite Christopher | S | 100,000 | $59.97 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.